Evolution of the Average Target: Sernova Biotherapeutics Inc

Evolution of the Target Price: Sernova Biotherapeutics Inc

Changes in Analyst Recommendations: Sernova Biotherapeutics Inc

94019df91f1b9dc5.TxxBsoZORAgiAsHVCrV-p9pK_ttwEuxG9gtEkScr7uM.A0or0esvNTpNUuyWYO9OxJQ_xu8mS70kj00K-ktmiYkQSQffxSgzfXQ68Q~5af2c3a923c2fe6ba575da35dd10a1e1

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- - +309.09%
+16.75%
+18.99%
+6.2%
+47.78%
- - +14.26%
-1.74%
+40.79%
- - -
Average +56.52%
Weighted average by Cap. +17.05%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.1100CAD
Average target price
0.4500CAD
Spread / Average Target
+309.09%
High Price Target
0.4500CAD
Spread / Highest target
+309.09%
Low Price Target
0.4500CAD
Spread / Lowest Target
+309.09%

Analyst Consensus Detail

Consensus revision (last 18 months)

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.1100CAD
Average target price
0.4500CAD
Spread / Average Target
+309.09%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SVA Stock
  4. Consensus Sernova Biotherapeutics Inc